Novel systemic therapy in advanced non-small-cell lung cancer
Standard chemotherapy regimes (platinum-based combinations) for advanced non-small-cell lung cancer have reached their therapeutic limits. In the last few years standard chemotherapy has been supplemented by targeted therapy. Targeted therapy consists of tyrosine kinase inhibitors (TKIs) against epi...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
| Series: | Hamdan Medical Journal |
| Online Access: | http://www.hamdanjournal.org/article.asp?issn=2227-2437;year=2016;volume=9;issue=1;spage=39;epage=56;aulast=Tiut;type=0 |